| Primary |
| Glioblastoma |
23.8% |
| Anaplastic Astrocytoma |
19.0% |
| Astrocytoma |
11.9% |
| Glioblastoma Multiforme |
9.5% |
| Hodgkin's Disease |
9.5% |
| Glioma |
7.1% |
| Brain Oedema |
4.8% |
| Diuretic Therapy |
4.8% |
| Dyspepsia |
4.8% |
| Vomiting |
4.8% |
|
| Pulmonary Toxicity |
14.3% |
| Pneumonia |
10.7% |
| Pyrexia |
10.7% |
| Pulmonary Embolism |
7.1% |
| Accidental Overdose |
3.6% |
| Deafness |
3.6% |
| Epilepsy |
3.6% |
| Febrile Neutropenia |
3.6% |
| Hemiparesis |
3.6% |
| Hepatitis Toxic |
3.6% |
| Inappropriate Antidiuretic Hormone Secretion |
3.6% |
| Malignant Neoplasm Progression |
3.6% |
| Myelodysplastic Syndrome |
3.6% |
| Overdose |
3.6% |
| Restlessness |
3.6% |
| Sepsis |
3.6% |
| Thrombocytopenia |
3.6% |
| Toxicity To Various Agents |
3.6% |
| Vomiting |
3.6% |
| Weight Decreased |
3.6% |
|
| Secondary |
| Hodgkin's Disease |
21.7% |
| Medulloblastoma |
18.4% |
| Glioblastoma |
8.3% |
| Brain Neoplasm Malignant |
6.8% |
| Product Used For Unknown Indication |
6.4% |
| Gliosarcoma |
5.3% |
| Brain Neoplasm |
3.7% |
| Diffuse Large B-cell Lymphoma |
3.1% |
| Constipation |
2.6% |
| Astrocytoma |
2.4% |
| Epilepsy |
2.4% |
| Glioblastoma Multiforme |
2.4% |
| Glioma |
2.4% |
| Hypertension |
2.4% |
| Oligodendroglioma |
2.2% |
| Drug Use For Unknown Indication |
2.0% |
| Metastatic Malignant Melanoma |
2.0% |
| Non-hodgkin's Lymphoma |
2.0% |
| General Symptom |
1.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.8% |
|
| Cardiomyopathy |
18.6% |
| Convulsion |
8.6% |
| Jaundice Cholestatic |
8.6% |
| Incontinence |
7.1% |
| Nausea |
5.7% |
| Sepsis |
5.7% |
| Deafness |
4.3% |
| Myelodysplastic Syndrome |
4.3% |
| Respiratory Failure |
4.3% |
| Visual Impairment |
4.3% |
| Atrial Fibrillation |
2.9% |
| Death |
2.9% |
| Febrile Neutropenia |
2.9% |
| General Physical Health Deterioration |
2.9% |
| Hepatitis |
2.9% |
| Jaundice |
2.9% |
| Liver Function Test Abnormal |
2.9% |
| Multi-organ Failure |
2.9% |
| Prostate Cancer |
2.9% |
| Pseudomonas Infection |
2.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
11.7% |
| Glioblastoma |
11.7% |
| Prophylaxis |
11.7% |
| B-cell Lymphoma |
9.2% |
| Prophylaxis Against Graft Versus Host Disease |
8.3% |
| Glioblastoma Multiforme |
6.7% |
| Product Used For Unknown Indication |
5.8% |
| Chronic Lymphocytic Leukaemia |
5.0% |
| Malignant Glioma |
4.2% |
| Acute Myeloid Leukaemia |
3.3% |
| Premedication |
3.3% |
| Bone Disorder |
2.5% |
| Chemotherapy |
2.5% |
| Metastatic Malignant Melanoma |
2.5% |
| Non-hodgkin's Lymphoma |
2.5% |
| Oligodendroglioma |
2.5% |
| Anaphylactic Reaction |
1.7% |
| Anaplastic Astrocytoma |
1.7% |
| Central Nervous System Lymphoma |
1.7% |
| Multiple Myeloma |
1.7% |
|
| Deep Vein Thrombosis |
7.1% |
| Haematotoxicity |
7.1% |
| Neutropenia |
7.1% |
| Pulmonary Embolism |
7.1% |
| Reversible Posterior Leukoencephalopathy Syndrome |
7.1% |
| Staphylococcal Sepsis |
7.1% |
| Toxic Epidermal Necrolysis |
7.1% |
| Venoocclusive Disease |
7.1% |
| Anaemia |
3.6% |
| Cerebrovascular Accident |
3.6% |
| Cystitis Haemorrhagic |
3.6% |
| Death |
3.6% |
| Fatigue |
3.6% |
| Hypersensitivity |
3.6% |
| Interstitial Lung Disease |
3.6% |
| Malignant Glioma |
3.6% |
| Metastases To Bone Marrow |
3.6% |
| Metastatic Malignant Melanoma |
3.6% |
| Neoplasm |
3.6% |
| Pain In Jaw |
3.6% |
|
| Interacting |
| Brain Neoplasm |
35.3% |
| Gastritis |
23.5% |
| Simple Partial Seizures |
23.5% |
| Hiv Infection |
17.6% |
|
| Weight Decreased |
66.7% |
| Neutropenia |
33.3% |
|
